Taiwan · Delayed Price · Currency is TWD Sinphar Pharmaceutical Statistics
Total Valuation
TPE:1734 has a market cap or net worth of TWD 6.11 billion. The enterprise value is 6.90 billion.
| Market Cap | 6.11B |
| Enterprise Value | 6.90B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
TPE:1734 has 190.20 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 190.20M |
| Shares Outstanding | 190.20M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 9.61% |
| Owned by Institutions (%) | 3.16% |
| Float | 137.32M |
Valuation Ratios
The trailing PE ratio is 16.74.
| PE Ratio | 16.74 |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | 15.68 |
| P/OCF Ratio | 10.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.44, with an EV/FCF ratio of 17.70.
| EV / Earnings | 18.87 |
| EV / Sales | 2.05 |
| EV / EBITDA | 10.44 |
| EV / EBIT | 16.46 |
| EV / FCF | 17.70 |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.41.
| Current Ratio | 2.50 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 2.28 |
| Debt / FCF | 3.87 |
| Interest Coverage | 12.39 |
Financial Efficiency
Return on equity (ROE) is 9.76% and return on invested capital (ROIC) is 8.73%.
| Return on Equity (ROE) | 9.76% |
| Return on Assets (ROA) | 4.21% |
| Return on Invested Capital (ROIC) | 8.73% |
| Return on Capital Employed (ROCE) | 8.16% |
| Weighted Average Cost of Capital (WACC) | 4.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.53 |
Taxes
In the past 12 months, TPE:1734 has paid 47.25 million in taxes.
| Income Tax | 47.25M |
| Effective Tax Rate | 11.77% |
Stock Price Statistics
The stock price has increased by +9.07% in the last 52 weeks. The beta is 0.13, so TPE:1734's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +9.07% |
| 50-Day Moving Average | 31.04 |
| 200-Day Moving Average | 30.85 |
| Relative Strength Index (RSI) | 65.64 |
| Average Volume (20 Days) | 343,260 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1734 had revenue of TWD 3.37 billion and earned 365.75 million in profits. Earnings per share was 1.92.
| Revenue | 3.37B |
| Gross Profit | 1.46B |
| Operating Income | 419.39M |
| Pretax Income | 401.52M |
| Net Income | 365.75M |
| EBITDA | 660.10M |
| EBIT | 419.39M |
| Earnings Per Share (EPS) | 1.92 |
Balance Sheet
The company has 994.63 million in cash and 1.51 billion in debt, with a net cash position of -515.14 million or -2.71 per share.
| Cash & Cash Equivalents | 994.63M |
| Total Debt | 1.51B |
| Net Cash | -515.14M |
| Net Cash Per Share | -2.71 |
| Equity (Book Value) | 3.72B |
| Book Value Per Share | 18.11 |
| Working Capital | 1.52B |
Cash Flow
In the last 12 months, operating cash flow was 584.66 million and capital expenditures -194.71 million, giving a free cash flow of 389.95 million.
| Operating Cash Flow | 584.66M |
| Capital Expenditures | -194.71M |
| Depreciation & Amortization | 240.71M |
| Net Borrowing | -393.89M |
| Free Cash Flow | 389.95M |
| FCF Per Share | 2.05 |
Margins
Gross margin is 43.29%, with operating and profit margins of 12.44% and 10.85%.
| Gross Margin | 43.29% |
| Operating Margin | 12.44% |
| Pretax Margin | 11.91% |
| Profit Margin | 10.85% |
| EBITDA Margin | 19.58% |
| EBIT Margin | 12.44% |
| FCF Margin | 11.57% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.11%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 3.11% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 49.53% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 3.06% |
| Earnings Yield | 5.98% |
| FCF Yield | 6.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 2, 2025. It was a forward split with a ratio of 1.05.
| Last Split Date | Sep 2, 2025 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
TPE:1734 has an Altman Z-Score of 2.66 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 7 |